Basic Materials / Specialty ChemicalsIstanbul
$22.44
+0.94 (+4.37%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-62.2M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.3B
P/E
27.0x
↑EV/EBITDA
8.4x
↓ROE
5.8%
↑Gross Margin
32.0%
↑Debt/Equity
0.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+0.7%
FCF CAGR
—
FCF margin
-2.1%
FCF / Net income
-0.44x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.90B · net income $141.9M · FCF $-62.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.90B | $2.90B | $3.44B | $3.48B | $2.84B |
| Net Income | $141.9M | $141.9M | $-78.4M | $87.8M | $101.5M |
| EBITDA | $612.9M | $612.9M | $533.1M | $570.1M | $344.8M |
| EPS | 0.75 | 0.75 | -0.41 | 0.46 | 0.53 |
| Gross Margin | 32.0% | 32.0% | 22.2% | 19.2% | 22.8% |
| Operating Margin | 16.1% | 16.1% | 9.3% | 9.2% | 15.2% |
| Net Margin | 4.9% | 4.9% | -2.3% | 2.5% | 3.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.40 | 0.40 | 0.39 | 0.54 | 0.58 |
| Current Ratio | 1.27 | 1.27 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-62.2M | $-62.2M | $618.1M | $-351.3M | $-145.3M |
| Returns | |||||
| ROE | 5.8% | 5.8% | -3.4% | 4.6% | 8.3% |
| Valuation | |||||
| P/E | 27.04 | 27.04 | — | 33.93 | 26.31 |
| EV/EBITDA | 8.35 | 8.35 | 6.14 | 6.70 | 9.24 |
| P/B | 1.75 | 1.75 | 1.08 | 1.57 | 2.19 |
| Growth & Yield | |||||
| Revenue Growth | -15.8% | -15.8% | -1.1% | 22.6% | — |
| EPS Growth | 281.0% | 281.0% | -189.5% | -13.7% | — |
| Dividend Yield | 1.0% | 1.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
38.8%
EPS terminal req.
$1.99
Spread vs growth
242.3%
5Y implied EPS CAGR
26.4%
EPS terminal req.
$2.41
Spread vs growth
254.6%
10Y implied EPS CAGR
17.9%
EPS terminal req.
$3.88
Spread vs growth
263.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+48.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.41 → 0.75
Residual
+47.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.